226 related articles for article (PubMed ID: 32274730)
21. Atrasentan Reduces Albuminuria by Restoring the Glomerular Endothelial Glycocalyx Barrier in Diabetic Nephropathy.
Boels MG; Avramut MC; Koudijs A; Dane MJ; Lee DH; van der Vlag J; Koster AJ; van Zonneveld AJ; van Faassen E; Gröne HJ; van den Berg BM; Rabelink TJ
Diabetes; 2016 Aug; 65(8):2429-39. PubMed ID: 27207530
[TBL] [Abstract][Full Text] [Related]
22. Glomerular endothelial glycocalyx constitutes a barrier to protein permeability.
Singh A; Satchell SC; Neal CR; McKenzie EA; Tooke JE; Mathieson PW
J Am Soc Nephrol; 2007 Nov; 18(11):2885-93. PubMed ID: 17942961
[TBL] [Abstract][Full Text] [Related]
23. Aldosterone induces albuminuria via matrix metalloproteinase-dependent damage of the endothelial glycocalyx.
Butler MJ; Ramnath R; Kadoya H; Desposito D; Riquier-Brison A; Ferguson JK; Onions KL; Ogier AS; ElHegni H; Coward RJ; Welsh GI; Foster RR; Peti-Peterdi J; Satchell SC
Kidney Int; 2019 Jan; 95(1):94-107. PubMed ID: 30389198
[TBL] [Abstract][Full Text] [Related]
24. Heparanase is involved in the pathogenesis of proteinuria as a result of glomerulonephritis.
Levidiotis V; Freeman C; Tikellis C; Cooper ME; Power DA
J Am Soc Nephrol; 2004 Jan; 15(1):68-78. PubMed ID: 14694159
[TBL] [Abstract][Full Text] [Related]
25. Revisiting the glomerular charge barrier in the molecular era.
Harvey SJ; Miner JH
Curr Opin Nephrol Hypertens; 2008 Jul; 17(4):393-8. PubMed ID: 18660676
[TBL] [Abstract][Full Text] [Related]
26. Heparanase Increases Podocyte Survival and Autophagic Flux after Adriamycin-Induced Injury.
Abu-Tayeh Suleiman H; Said S; Ali Saleh H; Gamliel-Lazarovich A; Haddad E; Minkov I; Zohar Y; Ilan N; Vlodavsky I; Abassi Z; Assady S
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293542
[TBL] [Abstract][Full Text] [Related]
27. Renal tubular ACE-mediated tubular injury is the major contributor to microalbuminuria in early diabetic nephropathy.
Eriguchi M; Lin M; Yamashita M; Zhao TV; Khan Z; Bernstein EA; Gurley SB; Gonzalez-Villalobos RA; Bernstein KE; Giani JF
Am J Physiol Renal Physiol; 2018 Apr; 314(4):F531-F542. PubMed ID: 29187372
[TBL] [Abstract][Full Text] [Related]
28. Angiopoietins and diabetic nephropathy.
Gnudi L
Diabetologia; 2016 Aug; 59(8):1616-20. PubMed ID: 27207083
[TBL] [Abstract][Full Text] [Related]
29. Biology of the Heparanase-Heparan Sulfate Axis and Its Role in Disease Pathogenesis.
Vlodavsky I; Barash U; Nguyen HM; Yang SM; Ilan N
Semin Thromb Hemost; 2021 Apr; 47(3):240-253. PubMed ID: 33794549
[TBL] [Abstract][Full Text] [Related]
30. Heparanase: roles in cell survival, extracellular matrix remodelling and the development of kidney disease.
Rabelink TJ; van den Berg BM; Garsen M; Wang G; Elkin M; van der Vlag J
Nat Rev Nephrol; 2017 Apr; 13(4):201-212. PubMed ID: 28163306
[TBL] [Abstract][Full Text] [Related]
31. Modulation of heparan sulfate in the glomerular endothelial glycocalyx decreases leukocyte influx during experimental glomerulonephritis.
Rops AL; Loeven MA; van Gemst JJ; Eversen I; Van Wijk XM; Dijkman HB; van Kuppevelt TH; Berden JH; Rabelink TJ; Esko JD; van der Vlag J
Kidney Int; 2014 Nov; 86(5):932-42. PubMed ID: 24759151
[TBL] [Abstract][Full Text] [Related]
32. Glomerular endothelial cell injury and cross talk in diabetic kidney disease.
Fu J; Lee K; Chuang PY; Liu Z; He JC
Am J Physiol Renal Physiol; 2015 Feb; 308(4):F287-97. PubMed ID: 25411387
[TBL] [Abstract][Full Text] [Related]
33. Enalapril improves albuminuria by preventing glomerular loss of heparan sulfate in diabetic rats.
Reddi AS; Ramamurthi R; Miller M; Dhuper S; Lasker N
Biochem Med Metab Biol; 1991 Feb; 45(1):119-31. PubMed ID: 2015105
[TBL] [Abstract][Full Text] [Related]
34. Ulinastatin attenuates pulmonary endothelial glycocalyx damage and inhibits endothelial heparanase activity in LPS-induced ARDS.
Wang L; Huang X; Kong G; Xu H; Li J; Hao D; Wang T; Han S; Han C; Sun Y; Liu X; Wang X
Biochem Biophys Res Commun; 2016 Sep; 478(2):669-75. PubMed ID: 27498004
[TBL] [Abstract][Full Text] [Related]
35. Mutations in the heparan sulfate backbone elongating enzymes EXT1 and EXT2 have no major effect on endothelial glycocalyx and the glomerular filtration barrier.
Khalil R; Boels MGS; ; van den Berg BM; Bruijn JA; Rabelink TJ; Hogendoorn PCW; Baelde HJ
Mol Genet Genomics; 2022 Mar; 297(2):397-405. PubMed ID: 35103870
[TBL] [Abstract][Full Text] [Related]
36. Heparanase involvement in physiology and disease.
Nasser NJ
Cell Mol Life Sci; 2008 Jun; 65(11):1706-15. PubMed ID: 18425416
[TBL] [Abstract][Full Text] [Related]
37. Cell surface localization of heparanase on macrophages regulates degradation of extracellular matrix heparan sulfate.
Sasaki N; Higashi N; Taka T; Nakajima M; Irimura T
J Immunol; 2004 Mar; 172(6):3830-5. PubMed ID: 15004189
[TBL] [Abstract][Full Text] [Related]
38. No change in glomerular heparan sulfate structure in early human and experimental diabetic nephropathy.
van den Born J; Pisa B; Bakker MA; Celie JW; Straatman C; Thomas S; Viberti GC; Kjellen L; Berden JH
J Biol Chem; 2006 Oct; 281(40):29606-13. PubMed ID: 16885165
[TBL] [Abstract][Full Text] [Related]
39. Heparanase-1-induced shedding of heparan sulfate from syndecan-1 in hepatocarcinoma cell facilitates lymphatic endothelial cell proliferation via VEGF-C/ERK pathway.
Yu S; Lv H; Zhang H; Jiang Y; Hong Y; Xia R; Zhang Q; Ju W; Jiang L; Ou G; Zhang J; Wang S; Zhang J
Biochem Biophys Res Commun; 2017 Apr; 485(2):432-439. PubMed ID: 28209511
[TBL] [Abstract][Full Text] [Related]
40. Heparanase-driven inflammation from the AGEs-stimulated macrophages changes the functions of glomerular endothelial cells.
Xu G; Qin Q; Yang M; Qiao Z; Gu Y; Niu J
Diabetes Res Clin Pract; 2017 Feb; 124():30-40. PubMed ID: 28081450
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
